drugset / Trial / NCT01964560
A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the long-term safety, tolerability and efficacy of lacosamide (LCM) in pediatric subjects.
Timeline
- Start
- 2014-08-13
- Primary completion
- 2022-04-13
- Completion
- 2022-04-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lacosamide | Other / unclassified | 1 mg/kg | Oral |
| Subject | Lacosamide | Other / unclassified | 6 mg/kg | Oral |
| Subject | Lacosamide | Other / unclassified | 50 mg | Oral |
| Subject | Lacosamide | Other / unclassified | 300 mg | Oral |